Bromocriptine Inhibits Growth Hormone Release from Rat Pituitary Cells in Primary Culture
- 1 February 1984
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 175 (2) , 191-195
- https://doi.org/10.3181/00379727-175-41787
Abstract
The action of the potent dopamine receptor agonist bromocriptine was studied in primary cultures of rat anterior pituitary cells. Bromocriptine inhibited both prolactin and growth hormone release in a concentration-dependent manner. This effect was blocked by the dopamine receptor antagonist spiperone when the agonist and antagonist were added coincidently. Spiperone was unable to affect the actions of bromocriptine if added 1 min after bromocriptine application or later. Apparently dopamine receptors exist on both mammotrophs and somatotrophs in vitro.This publication has 4 references indexed in Scilit:
- Biological activity of a growth hormone-releasing factor secreted by a human tumorAmerican Journal of Physiology-Endocrinology and Metabolism, 1983
- Evidence for Paracrine Interaction between Gonadotrophs and Lactotrophs in Pituitary Cell Aggregates*Endocrinology, 1983
- Mammosomatotroph cell adenoma of the human pituitary: a morphologic entityVirchows Archiv, 1983
- SELECTIVE GROWTH HORMONE AND CYCLIC AMP STIMULATING ACTIVITY IS PRESENT IN A HUMAN PANCREATIC ISLET CELL TUMORJournal of Clinical Endocrinology & Metabolism, 1982